Understanding APC - malecare.org

Efficacy of a Modified Androgen Blockade in Prostate Cancer Patients with Biochemical Failure

How to best treat men with a prostate cancer PSA only recurrence (biochemical recurrence) still remains controversial. Hormone therapy (ADT) using a combination of a 5-alpha reductase inhibitor and an antiandrogen without conventional gonadal androgen suppression (where testosterone levels are not suppressed) may allow control of the prostate-specific antigen (PSA) with less morbidity. METHODS: In [...]

By Malecare|2017-10-19T10:51:37-04:00December 21st, 2011|adjuvant therapy, Advanced Prostate Cancer, Drugs & Treatments, General Information, Hormone Therapy, Research, Uncategorized, Understanding APC|1 Comment

A Look at the Status of Cancer Vaccines – Emerging Treatments

From very early on, researchers and doctors have dreamed of using the body’s own immune system to fight cancer. The big question has been why doesn’t the immune system attack the tumor cells that invade healthy tissue? The really good news is that finally science is catching up with this vision. Therapeutic cancer vaccines that [...]

By Malecare|2011-12-20T14:34:32-05:00December 20th, 2011|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, ipilimumab, Prostvac, Provenge, Research, Uncategorized, Understanding APC, vaccines, Yervoy|1 Comment

Dr. Mark Scholz Discusses Treatment Issues For Advanced Prostate Cancer

At the recent 2011 Prostate Cancer Research Institute Dr. Mark Scholz discussed care issues for men with advanced metastatic prostate cancer. In his presentation he stressed the importance of closely monitoring each man’s individual, on-going response to treatment to determine its effectiveness. He made a case that without close monitoring; treatment decisions would lag behind [...]

By Malecare|2017-10-19T10:51:52-04:00December 17th, 2011|Advanced Prostate Cancer, carboplatin, Chemo Therapy, Custirsen, Drugs & Treatments, Uncategorized, Understanding APC|1 Comment

The Expression Of Prostatic Acid Phosphatase In Prostate Cancer Bone Metastases

One of the major causes of prostate cancer morbidity and mortality is bone metastases. Currently, when it comes to treating prostate cancer metastases we are very limited in effective therapies that actually prolong survival. Kirschenbaum A, etal (Departments of Urology and Medicine Division of Pulmonary Diseases Division of Endocrinology, Metabolism, and Bone Diseases, Mount Sinai [...]

By Malecare|2017-10-19T10:51:53-04:00December 13th, 2011|Advanced Prostate Cancer, Bone Metastases, General Information, Metastases, Research, Uncategorized, Understanding APC|1 Comment

Osteonecrosis Of The Jaw While Taking Zometa & Xgeva

The use of denosumab (Xgeva) as an alternative to the more commonly prescribed zoledronic acid (Zometa) to slow down the development of bone metastases in men with advanced prostate cancer is becoming more common. The most common concern for men taking Zometa and now Xgeva has been osteonecrosis of the jaw. Osteonecrosis of the jaw [...]

By Malecare|2017-10-19T10:51:53-04:00December 12th, 2011|Advanced Prostate Cancer, bisphosphonates, denosumab - Prolia, denosumab - Xgeva, Drugs & Treatments, Uncategorized, Understanding APC, Zometa|9 Comments